PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1211712
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1211712
Cell Lysis & Disruption Market size was valued at USD 5,107.4 Million in 2022, expanding at a CAGR of 10.3% from 2023 to 2030.
Cell lysis and disruption is a technique that involves rupturing the cell membrane to liberate intercellular substances including deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins from a cell. These procedures play a key role in immunoassays for point-of-care diagnostics, downstream processes such as protein extraction for the study of protein function and structure, drug screening, and mRNA transcriptome determination.
Market Dynamics
These methods are utilised for the reliable, competent, and efficient release of substances. Additionally, it enhances possible advancements, which promotes the expansion of the global lysis & disruption systems industry. Additionally, the instruments' rising popularity offers a high yield, the ability to lyse cells, ease of cleaning, assurance of scalability, and maximisation of the active ingredient. Many common tools, including the polytron homogenizer and blender, are useful in removing proteins from massive amounts of human connective tissue and disturbing enormous amounts of yeast samples.
In the cell lysis & disruption market, numerous instrument manufacturers are creating a variety of equipment to perform cell lysis processes. All of these advantages, therefore, increasing demand for the equipment required for cell lysis, which in turn propels the expansion of the lysis & disruption systems market in the following years. Numerous government agencies assist by raising funds, making investments, and awarding grants.
Segmental Analysis:
Based on application, the protein isolation segment is expected to dominate the market over the forecast period. To extract proteins with the least amount of oxidation and protein breakdown, there is an increasing need for effective and quick lysis techniques. Additionally, improvements in highly advanced bioprocessing machinery and reagents drive the segment's expansion. Because of these advantages, protein isolation has a monopoly on the market for cellular disruption systems.
Based on end use, the segment for pharmaceutical and biotechnology companies held the largest revenue share in 2022. The increasing presence of the largest number of biotechnology businesses that use lysis methods to find molecular biology and bioprocess approaches with the potential to treat clinical illnesses that could not be cured before along with the efficiency and safety offered by biopharmaceuticals products are driving the expansion of the cell lysis & disruption industry.
Regional Analysis:
In 2022, North America will hold the highest revenue share in the market for lysis and disruption systems. The regional cellular disruption market is dominated by factors including the government's increasing emphasis on funding precision pharmaceuticals, molecular biology research, and cancer research. The demand for lysis & disruption systems in North America is also going to be stimulated by rising R&D activities in the healthcare sector to find unique drug patterns and medicines for treating rare diseases or health concerns.
Recent Development:
In January 2021, The manufacturing of viral vectors by Novasep, Henogen S.A., was acquired by Thermo Fisher Scientific, Inc. This improved the company's cell lysis and disruption business, which is a necessary step in the production process, as well as the company's capacity for gene and cell therapies and vaccines.
Key features of the study:
This proposed research study on the Cell Lysis & Disruption market provides market size (US$ Million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Cell Lysis & Disruption market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cell Lysis & Disruption market
The impact of COVID-19 on the Cell Lysis & Disruption market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Cell Lysis & Disruption market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Cell Lysis & Disruption market, we have also included a competitive landscape and key innovator analysis for the Cell Lysis & Disruption market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Cell Lysis & Disruption market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Cell Lysis & Disruption market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELL LYSIS & DISRUPTION MARKET KEY PLAYERS
Becton Dickinson & Company (BD)
Merck KGaA
F. Hoffmann-La Roche Ltd.
Danaher Corp.
Thermo Fisher Scientific, Inc.
Qiagen NV
Microfluidics International Corp.
Miltenyi Biotec GmbH
Claremont BioSolutions, LLC
Bio-Rad Laboratories, Inc.
Parr Instrument Company
BioVision, Inc.
Covaris, Inc.
Qsonica LLC
GLOBAL CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE
Reagent-Based
Physical Disruption
GLOBAL CELL LYSIS & DISRUPTION MARKET, BY PRODUCT
Instruments
Reagents & Consumables
GLOBAL CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE
Mammalian cells
Bacterial cells
Yeast/Algae/Fungi
Plant cells
GLOBAL CELL LYSIS & DISRUPTION MARKET, BY APPLICATION
Protein Isolation
Downstream Processing
Cell organelle isolation
Nucleic acid isolation
GLOBAL CELL LYSIS & DISRUPTION MARKET, BY END USE
Academic & Research Institutes
Hospitals & Diagnostic Labs
Cell Banks
Pharmaceutical & Biotechnology Companies
GLOBAL CELL LYSIS & DISRUPTION MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA